NCT03252028

Brief Summary

Background: Due to anatomical restrictions, the inflammatory response to intra-cerebral bacterial infections exposes swollen brain tissues to pressure and ischemia, resulting in life-threatening damage. However, diagnosing meningitis in patients after neurosurgery is complicated, due to brain tissue damage and changes in cerebrospinal fluid (CSF) caused by surgery. Hepatocyte growth factor (HGF) is a local, acute-phase protein. Previous studies on community-acquired septic meningitis reported high levels of intrathecal-produced HGF. Aim: The aim of present study is to evaluate a new platform for qualitative determination of HGF in body fluids and revealing the site of injury. Method: Based on a reverse-methachromacy method, strips are prepared. The surface on the strip changes colour to blue upon contact with HGF. Plan: CSF, urine and sputum of patients that develop fever post neurosurgery are analysed with the test and the results compared with conventional diagnostic methods. Clinical value: A rapid, equipment-free test gives the opportunity to identify the infectious focus in the infected organ long before culture results are available.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2015

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 2, 2015

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

August 13, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 17, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

August 21, 2017

Status Verified

August 1, 2017

Enrollment Period

4 years

First QC Date

August 13, 2017

Last Update Submit

August 18, 2017

Conditions

Keywords

Hepatocyte growth factor, Nosocomial infections, VAP, Meningitis, In vitro, point of care, rapid test

Outcome Measures

Primary Outcomes (1)

  • detection of infections in intensive care unit

    analyse of different body fluids to detect the focus of infections post neurosurgical fever

    4 years

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

all post-neurosurgical patients in neuro intensive care unit university hospital Linkoping, Sweden

You may qualify if:

  • all post neurosurgical patients with suspect infection or fever

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Neurosurgery dept. University Hospital

Linköping, Östergötland County, 581 85, Sweden

RECRUITING

Neurosurgery department, University Hospital

Linköping, Östergötland County, 58185, Sweden

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Samples from CSF, Sputum, Urine, Blood

MeSH Terms

Conditions

Bacterial InfectionsMeningitis, BacterialCross InfectionDeafness, Autosomal Recessive 39Meningitis

Condition Hierarchy (Ancestors)

Bacterial Infections and MycosesInfectionsCentral Nervous System Bacterial InfectionsCentral Nervous System InfectionsCentral Nervous System DiseasesNervous System DiseasesNeuroinflammatory DiseasesIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Annette Theodorsson, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, PhD, associated professor

Study Record Dates

First Submitted

August 13, 2017

First Posted

August 17, 2017

Study Start

December 2, 2015

Primary Completion

December 1, 2019

Study Completion

December 1, 2020

Last Updated

August 21, 2017

Record last verified: 2017-08

Locations